Ra Pharmaceuticals, Inc. (RARX) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 192 transactions totaling $158.2M, demonstrating a bullish sentiment with $130.3M in net insider flow. The most recent transaction on Apr 2, 2020 involved a transaction of 4,858,260 shares valued at $233.2M.
No significant insider buying has been recorded for RARX in the recent period.
No significant insider selling has been recorded for RARX in the recent period.
Based on recent SEC filings, insider sentiment for RARX is bullish with an Insider Alignment Score of 91/100 and a net flow of $130.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Ra Pharmaceuticals, Inc. (RARX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading RARX stock, having executed 192 transactions in the past 90 days. The most active insider is Rajeev M. Shah (Executive), who has made 6 transactions totaling $265.9M.
Get notified when executives and directors at RARX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 2, 2020 | Healthcare Fund Lp Ra Capital | Executive | Disposition | 4,858,260 | $48.00 | $233.2M | Large |
| Apr 2, 2020 | M. Shah Rajeev | Executive | Disposition | 4,858,260 | $48.00 | $233.2M | Large |
| Apr 2, 2020 | C. King John | Executive | Disposition | 10,823 | $48.00 | $519.5K | Large |
| Apr 2, 2020 | Farzaneh-far Ramin | Executive | Disposition | 14,492 | $48.00 | $695.6K | Large |
| Apr 2, 2020 | Read Simon | Executive | Disposition | 12,595 | $48.00 | $604.6K | Large |
| Apr 2, 2020 | Ricardo Alonso | Executive | Disposition | 2,973 | $48.00 | $142.7K | |
| Apr 2, 2020 | Charles Lubner David | Executive | Disposition | 15,622 | $48.00 | $749.9K | Large |
| Apr 2, 2020 | A. Treco Douglas | Executive | Disposition | 234,707 | $48.00 | $11.3M | Large |
| Apr 2, 2020 | Gp, Ltd Nea 13 | Executive | Disposition | 6,135,234 | $N/A | $0 | |
| Mar 17, 2020 | Ricardo Alonso | Executive | Sale | 2,288 | $44.25 | $101.2K | |
| Mar 16, 2020 | Farzaneh-far Ramin | Executive | Sale | 10,595 | $45.16 | $478.5K | |
| Mar 16, 2020 | Farzaneh-far Ramin | Executive | Option Exercise | 1,389 | $5.60 | $7.8K | |
| Mar 16, 2020 | Farzaneh-far Ramin | Executive | Option Exercise | 9,206 | $5.60 | $51.6K | |
| Feb 18, 2020 | Farzaneh-far Ramin | Executive | Sale | 10,595 | $46.61 | $493.8K | |
| Feb 18, 2020 | Farzaneh-far Ramin | Executive | Option Exercise | 9,206 | $5.60 | $51.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Disposition(D) | 9 | $480.4M | 75.1% |
Purchase(P) | 24 | $144.2M | 22.5% |
Sale(S) | 60 | $14.0M | 2.2% |
Exercise(M) | 32 | $794.2K | 0.1% |
Payment(F) | 5 | $431.4K | 0.1% |
Exercise (Options)(X) | 13 | $69.7K | 0.0% |
Conversion(C) | 49 | $0 | 0.0% |
Insiders at Ra Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 26 insiders making 192 transactions totaling $144.2M in purchases versus $14.0M in sales, the net buying activity of $130.3M signals strong executive confidence. Rajeev M. Shah (Executive) leads the buying activity with $265.9M in transactions across all time.